Authors: Matalliotakis, IM Athanassakis, I Goumenou, AG Neonaki, MA Koumantakis, EE Vassiliadis, S Koumantakis, EE

Citation: Im. Matalliotakis et al., The possible anti-inflammatory role of circulating human leukocyte antigenlevels in women with endometriosis after treatment with danazol and leuprorelin acetate depot, MEDIAT INFL, 10(2), 2001, pp. 75-80

Authors: Matalliotakis, IM Vassiliadis, S Goumenou, AG Athanassakis, I Koumantakis, GE Neonaki, MA Koumantakis, EE

Citation: Im. Matalliotakis et al., Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment, J REPRO IMM, 51(1), 2001, pp. 9-19

Authors: Matalliotakis, IM Neonaki, MA Panidis, DK Goumenou, AG Koumantakis, EE

Citation: Im. Matalliotakis et al., Three-year follow-up of [CA-125, CA 19-9, CA 15-3, SIL-2R, IL-6, IL-1a, TNF-a, sCD8 and sCD4] levels in a woman with severe endometriosis, EUR J OB GY, 93(2), 2000, pp. 127-129

Authors: Matalliotakis, IM Neonaki, MA Koumantaki, YG Goumenou, AG Kyriakou, DS Koumantakis, EE

Citation: Im. Matalliotakis et al., A randomized comparison of danazol and leuprolide acetate suppression of serum-soluble CD23 levels in endometriosis, OBSTET GYN, 95(6), 2000, pp. 810-813

Authors: Matalliotakis, IM Koumantaki, YG Neonaki, MA Goumenou, AG Koumantakis, GE Kyriakou, DS Koumantakis, EE

Citation: Im. Matalliotakis et al., Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments, AM J OBST G, 183(1), 2000, pp. 58-62